These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12352913)

  • 61. Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial.
    Witzke O; Nitschke M; Bartels M; Wolters H; Wolf G; Reinke P; Hauser IA; Alshuth U; Kliem V
    Transplantation; 2018 May; 102(5):876-882. PubMed ID: 29166336
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Co-infection and clinical impact of human herpesvirus 5 and 6 in liver transplantation.
    Sampaio AM; Guardia AC; Milan A; Sasaki AN; Andrade PD; Bonon SH; Stucchi RS; Botelho Costa SC; Boin IF
    Transplant Proc; 2012 Oct; 44(8):2455-8. PubMed ID: 23026619
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.
    Paya CV; Wilson JA; Espy MJ; Sia IG; DeBernardi MJ; Smith TF; Patel R; Jenkins G; Harmsen WS; Vanness DJ; Wiesner RH
    J Infect Dis; 2002 Apr; 185(7):854-60. PubMed ID: 11920308
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients.
    Imbert-Marcille BM; Cantarovich D; Ferre-Aubineau V; Richet B; Soulillou JP; Billaudel S
    Transplantation; 1997 May; 63(10):1476-81. PubMed ID: 9175813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction.
    Tong CY; Cuevas LE; Williams H; Bakran A
    Transplantation; 2000 Mar; 69(5):985-91. PubMed ID: 10755562
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Human beta-herpesvirus interactions in solid organ transplant recipients.
    Mendez JC; Dockrell DH; Espy MJ; Smith TF; Wilson JA; Harmsen WS; Ilstrup D; Paya CV
    J Infect Dis; 2001 Jan; 183(2):179-184. PubMed ID: 11120923
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?
    Abecassis MM; Koffron AJ; Kaplan B; Buckingham M; Muldoon JP; Cribbins AJ; Kaufman DB; Fryer JP; Stuart J; Stuart FP
    Transplantation; 1997 Jan; 63(2):275-9. PubMed ID: 9020330
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CMV viral load measurements in whole blood and plasma--which is best following renal transplantation?
    Barrett-Muir W; Breuer J; Millar C; Thomas J; Jeffries D; Yaqoob M; Aitken C
    Transplantation; 2000 Jul; 70(1):116-9. PubMed ID: 10919585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosis and monitoring of cytomegalovirus infection after liver transplantation in children.
    Kaliciński P; Kamiński A; Prokurat A; Drewniak T; Chrupek M; Ochalska B; Dzierzanowska D; Szymczak M; Ismail H; Pawłowska J; Kamiński W
    Ann Transplant; 1996; 1(2):13-4. PubMed ID: 9869923
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
    Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
    Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytomegalovirus load in whole blood is more reliable for predicting and assessing CMV disease than pp65 antigenaemia.
    Hardie DR; Korsman SN; Hsiao NY
    J Virol Methods; 2013 Oct; 193(1):166-8. PubMed ID: 23792685
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
    van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
    Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapid identification of cytomegalovirus in liver allograft biopsies by in situ hybridization.
    Masih AS; Linder J; Shaw BW; Wood RP; Donovan JP; White R; Markin RS
    Am J Surg Pathol; 1988 May; 12(5):362-7. PubMed ID: 2834972
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome.
    Arnold JC; Nouri-Aria KT; O'Grady JG; Portmann BC; Alexander GJ; Williams R
    Clin Investig; 1993 Mar; 71(3):191-6. PubMed ID: 8386961
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sequencing of Cell-Free DNA to Monitor Cytomegalovirus Infection After Liver Transplant.
    Li J; Tan J; Chen G; Li Q; Zhou Z; Bin Y; Qi H; Si Z
    Exp Clin Transplant; 2021 Apr; 19(4):331-338. PubMed ID: 33641659
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of concern "The role of the CD95, CD38 and TGFβ1 during active human cytomegalovirus infection in liver transplantation" [Cytokine 35(3-4) (2006) 193-199].
    Wang Y; Liu Y; Zhang Y; Peng L; Ma J; Tang Z; Gao W; Zhu Z; Yao Z
    Cytokine; 2024 Apr; 176():156524. PubMed ID: 38388069
    [No Abstract]   [Full Text] [Related]  

  • 79. Risk of Neurodegenerative Disease after Viral Infections: The Increasing Load of Evidence.
    Holgado C; Lopez G; Castillo-Torres SA
    Mov Disord Clin Pract; 2023 Sep; 10(9):1302-1303. PubMed ID: 37772288
    [No Abstract]   [Full Text] [Related]  

  • 80. Cytomegalovirus infection after liver transplantation: viral load as a guide to treating clinical infection.
    Norris S; Kosar Y; Donaldson N; Smith HM; Zolfino T; O'Grady JG; Muiesan P; Rela M; Heaton N
    Transplantation; 2002 Aug; 74(4):527-31. PubMed ID: 12352913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.